|
|
||||||||
Journal of General Virology, Vol 80, 1263-1269, Copyright © 1999 by Society for General Microbiology
ARTICLES |
AN Zakhartchouk, C Pyne, GK Mutwiri, Z Papp, ME Baca-Estrada, P Griebel, LA Babiuk and SK Tikoo
Veterinary Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Canada S7N 5E3
To determine the potential of replication-competent (E3-deleted) bovine adenovirus-3 (BAV-3) as a delivery system for vaccine antigens in calves, we evaluated the ability of recombinant BAV-3 expressing different forms of of bovine herpesvirus-1 (BHV-1) glycoprotein gD to protect against BHV-1 infection in calves that had pre-existing BAV-3 specific antibodies. Three- to four-month-old calves, vaccinated intranasally with recombinant BAV-3 expressing full-length gD (BAV3.E3gD) or a truncated version of gD (gDt) (BAV3.E3gDt), or with E3-deleted BAV-3 (BAV3.E3d; control), were challenged with BHV-1 strain 108. Vaccination with BAV3.E3gD or BAV3.E3gDt induced gD-specific antibody responses in serum and nasal secretions, and primed calves for gD-specific lymphoproliferative responses. In addition, all calves developed complement-independent neutralizing antibodies against BHV-1. Protection against viral challenge was observed in calves vaccinated with recombinant BAV3.E3gD or BAV3.E3gDt as shown by a significant reduction in body temperature and clinical disease, and a partial reduction in the amount and duration of virus excretion in nasal secretions. These results indicate that replication-competent BAV-3-based vectors can induce protective immune responses in calves (the natural host) that have pre-existing BAV-3-specific antibodies.
This article has been cited by other articles:
![]() |
L. Xing and S. K. Tikoo E1A promoter of bovine adenovirus type 3 J. Gen. Virol., December 1, 2006; 87(12): 3539 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Rosenberg Interview with Dr. Philip Griebel regarding Pivotal Advance: Passively acquired membrane proteins alter the functional capacity of bovine polymorphonuclear cells J. Leukoc. Biol., September 1, 2006; 80(3): 479 - 480. [Full Text] [PDF] |
||||
![]() |
T. A. Whale, T. K. Beskorwayne, L. A. Babiuk, and P. J. Griebel Bovine polymorphonuclear cells passively acquire membrane lipids and integral membrane proteins from apoptotic and necrotic cells J. Leukoc. Biol., June 1, 2006; 79(6): 1226 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xing, L. Zhang, J. V. Kessel, and S. K. Tikoo Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA J. Gen. Virol., November 1, 2003; 84(11): 2947 - 2956. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Reddy, N. Idamakanti, Y. Chen, T. Whale, L. A. Babiuk, M. Mehtali, and S. K. Tikoo Replication-Defective Bovine Adenovirus Type 3 as an Expression Vector J. Virol., November 1, 1999; 73(11): 9137 - 9144. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Reddy, N. Idamakanti, L. A. Babiuk, M. Mehtali, and S. K. Tikoo Porcine adenovirus-3 as a helper-dependent expression vector J. Gen. Virol., November 1, 1999; 80(11): 2909 - 2916. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |